361 Capital’s Eastman Chemical EMN Stock Holding History

361 Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,029	Closed	-$637K	–	339
2018 Q1	$637K	Buy	+6,029	New	+$610K	0.16%	247
2017 Q1	–	Sell	-83,178	Closed	-$6.26M	–	178
2016 Q4	$6.26M	Buy	+83,178	New	+$6.01M	1.49%	32

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

361 Capital's EMN Position: Q2 2018 in Review

361 Capital sold out of Eastman Chemical (EMN) in Q2 2018, closing a stake of 6,029 shares — an estimated $637K sold.

361 Capital first reported a position in EMN in Q4 2016 and held it in 2 quarters. The position peaked at $6.26M in Q4 2016. 726 funds tracked by Wall St. Rank hold EMN as of Q2 2018.

361 Capital reported no remaining Eastman Chemical position as of Q2 2018 after selling out during the quarter.
361 Capital sold 6,029 Eastman Chemical shares in Q2 2018, an estimated $637K.
361 Capital first reported a position in Eastman Chemical in Q4 2016 and held it in 2 quarters.
361 Capital's Eastman Chemical position peaked at $6.26M in Q4 2016.
726 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2018.

Based on 361 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.